An update on Curcuma as a functional food in the control of cancer and inflammation

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 18, Issue 6, 2015, Pages 605-611

  Schaffer, Moshe ^a,b,c   Schaffer, Pamela M ^c,d   Bar Sela, Gil ^e  

^a BARUCH PADEH MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c UNIVERSITY OF ORADEA   (Romania)

^d Department of Gynaecology   (Germany)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Anti inflammatory; Anticancer; Curcumin

Indexed keywords

CURCUMIN; LIPOSOME; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; PLANT EXTRACT; TURMERIC EXTRACT;

ALZHEIMER DISEASE; ARTHRITIS; BREAST CANCER; CANCER CONTROL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CONDYLOMA ACUMINATUM; CURCUMA; DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FUNCTIONAL FOOD; GINGIVITIS; HEAD AND NECK CANCER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; LICHEN PLANUS; MALIGNANT NEOPLASTIC DISEASE; MICELLE; MULTIPLE MYELOMA; NANOENCAPSULATION; NONHUMAN; PANCREAS CANCER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POLYMERIZATION; PROSTATE CANCER; RADIATION DERMATITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ULCERATIVE COLITIS; INFLAMMATION; NEOPLASMS;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CURCUMA; CURCUMIN; FUNCTIONAL FOOD; HUMANS; INFLAMMATION; NEOPLASMS; PLANT EXTRACTS;

EID: 84944032421     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000227     Document Type: Review

References (43)

1. Bandyopadhyay D, Banik BK. Bismuth nitrate-induced microwave-Assisted expeditious synthesis of vanillin from curcumin. Org Med Chem Lett 2012; 2:15.
2. Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 2011; 16:4567-4598.
3. Schaffer M, Schaffer PM, Zidan J, Bar Sela G. Curcuma as a functional food in the control of cancer and inflammation. Curr Opin Clin NutrMetab Care 2011; 14:588-597.
4. Picone P, Nuzzo D, Caruana L, et al. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of AKT and Foxo3a nuclear translocation. Free Radic Res 2014; 48:1397-1408.
5. Zikaki K, Aggeli IK, Gaitanaki C, Beis I. Curcumin induces the apoptotic intrinsic pathway via upregulation of reactive oxygen species and JNKs in H9c2 cardiac myoblasts. Apoptosis 2014; 19:958-974.
6. Liu H, Liu YZ, Zhang F, et al. Identification of potential pathways involved in the induction of cell cycle arrest and apoptosis by a new 4-Arylidene curcumin analogue T63 in lung cancer cells: a comparative proteomic analysis. Mol Biosyst 2014; 10:1320-1331.
7. Rana C, Piplani H, Vaish V, et al. Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and curcumin in colon cancer. Mol Cell Biochem 2015; 402:225-241.
8. Dang YP, Yuan XY, Tian R, et al. Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-kB-p53-caspase-3 pathway. Exp Ther Med 2015; 9:1470-1476.
9. Qian Y, Ma J, Guo X, et al. Curcumin enhances the radiosensitivity of U87 cells by inducing DUSP-2 up-regulation. Cell Physiol Biochem 2015; 35:1381-1393.
10. Shanmugam MK, Rane G, Kanchi MM, et al. The multifaceted role of curcumin in cancer prevention and treatment. Molecules 2015; 20:2728-2769.
11. Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 2006; 25:278-287.
12. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978; 43:86-92.
13. Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7:1894-1900.
14. Larmonier CB, Midura-Kiela MT, Ramalingam R, et al. Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:503-515.
15. Barenholz Y. Doxil1-The first FDA-Approved nano-drug: lessons learned. J Control Release 2012; 160:117-134.
16. Malam Y, Loizidou M, Seifalian AM. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 2009; 30:592-599.
17. Karewicz A, Bielska D, Gzyl-Malcher B, et al. Interaction of curcumin with lipid monolayers and liposomal bilayers. Colloids Surf B Biointerfaces 2011; 88:231-239.
18. Waghela BN, Sharma A, Dhumale S, et al. Curcumin conjugated with PLGA potentiates sustainability, antiproliferative activity and apoptosis in human colon carcinoma cells. PLoS One 2015; 10:e0117526.
19. Lu Y, Park K. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 2013; 453:198-214.
20. Song L, Shen Y, Hou J, et al. Polymeric micelles for parenteral delivery of curcumin: preparation, characterization and in vitro evaluation. Colloid Surf A 2011; 390:25e32.
21. Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 2014; 35:3365-3383.
22. Vareed SK, Kakarala M, Ruffin MT, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidem Biomar 2008; 17:1411-1417.
23. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S Jr. High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol 2012; 66:752-760.
24. Basu P, Dutta S, Begum R, et al. Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study. Asian Pac J Cancer Prev 2013; 14:5753-5759.
25. Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 2011; 4:354-364.
26. He ZY, Shi CB, Wen H, et al. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Investig 2011; 29:208-213.
27. Golombick T, Diamond TH, Manoharan A, Ramakrishna R. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4 g study and an open-label 8 g extension study. Am J Hematol 2012; 87:455-460.
28. Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 2011; 68:157-164.
29. Epelbaum R, Schaffer M, Vizel B, et al. Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 2010; 62:1137-1141.
30. KanaiM, Otsuka Y, Otsuka K, et al. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol 2013; 71:1521-1530.
31. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther 2010; 9:8-14.
32. Ide H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate specific antigen. Prostate 2010; 70:1127-1133.
33. Kim SG, Veena MS, Basak SK, et al. Curcumin treatment suppresses IKKbeta kinase activity of salivary cells of patients with head and neck cancer: a pilot study. Clin Cancer Res 2011; 17:5953-5961.
34. Ghalaut VS, Sangwan L, Dahiya K, et al. Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. J Oncol Pharm Pract 2012; 18:186-190.
35. Ryan JL, Heckler CE, Ling M, et al. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat Res 2013; 180:34-43.
36. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 2012; 26:1719-1725.
37. Paschoal MA, Moura CM, Jeremias F, et al. Longitudinal effect of curcuminphotodynamic antimicrobial chemotherapy in adolescents during fixed orthodontic treatment: a single-blind randomized clinical trial study. Lasers Med Sci 2014. [Epub ahead of print]
38. Chuengsamarn S, Rattanamongkolgul S, Phonrat B, et al. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. Nutr Biochem 2014; 25:144-150.
39. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, et al. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012; 35:2121-2127.
40. Lang A, Salomon N, Wu JC, et al. Curcumin in combination with mesalamine induces remission in patients with mild-To-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 2015; 13:1444-1449.
41. Singla V, Pratap Mouli V, Garg SK, et al. Induction with NCB-02 (curcumin) enema for mild-To-moderate distal ulcerative colitis -A randomized, placebocontrolled, pilot study. J Crohns Colitis 2014; 8:208-214.
42. Ringman JM, Frautschy SA, Teng E, et al. Oral curcumin for Alzheimers disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012; 4:43.
43. Hishikawa N, Takahashi Y, Amakusa Y, et al. Effects of turmeric on Alzheimers disease with behavioral and psychological symptoms of dementia. Ayu 2012; 33:499-504.